Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corcept Therapeutics

70.45
-1.3200-1.84%
Volume:746.49K
Turnover:52.82M
Market Cap:7.42B
PE:63.21
High:71.79
Open:71.63
Low:70.03
Close:71.77
Loading ...

Corcept Therapeutics says Phase 3 ROSELLA trial met primary endpoint

TIPRANKS
·
02 Jun

Top Executive Sells Thousands in Corcept Therapeutics Stock!

TIPRANKS
·
23 May

Chief Business Officer Gary Charles Robb Reports Disposal of Common Shares in Corcept Therapeutics Inc

Reuters
·
23 May

Director’s Major Stock Sale Shakes Up Corcept Therapeutics

TIPRANKS
·
21 May

William Guyer, Chief Development Officer, Reports Disposal of Common Shares of Corcept Therapeutics Inc

Reuters
·
21 May

Stock Track | Corcept Therapeutics Plummets 9% on Analyst Downgrades and Insider Selling

Stock Track
·
06 May

Truist Cuts Price Target on Corcept Therapeutics to $135 From $150, Keeps Buy Rating

MT Newswires Live
·
06 May

Stock Track | Corcept Therapeutics Plunges 5.33% Pre-Market Amid Insider Selling and Analyst Price Target Cuts

Stock Track
·
06 May

Corcept Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
06 May

Piper Sandler Keeps Their Buy Rating on Corcept Therapeutics (CORT)

TIPRANKS
·
06 May

Corcept Therapeutics: Strong Growth Potential and Promising Pipeline Support Buy Rating

TIPRANKS
·
06 May

Corcept Therapeutics price target lowered to $145 from $150 at H.C. Wainwright

TIPRANKS
·
06 May

Sean Maduck, President of Corcept Endocrinology, Reports Disposal of Common Shares of Corcept Therapeutics Incorporated

Reuters
·
06 May

Joseph Douglas Lyon, Officer, Reports Disposal of Common Shares of Corcept Therapeutics Incorporated

Reuters
·
06 May

Corcept Therapeutics (CORT) Meets Q1 Earnings Estimates

Zacks
·
06 May

Corcept (NASDAQ:CORT) Misses Q1 Sales Targets, Stock Drops

StockStory
·
06 May

Corcept Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
06 May

Corcept Therapeutics Q1 Earnings Decrease, Revenue Rises -- Shares Fall After Hours

MT Newswires Live
·
06 May

Corcept Therapeutics Q1 EPS $0.17 Beats $0.14 Estimate, Sales $157.21M Miss $177.94M Estimate

Benzinga
·
06 May

BRIEF-Corcept Therapeutics Q1 EPS USD 0.17 Vs. IBES Estimate USD 0.14

Reuters
·
06 May